We came across a bullish thesis on Harrow, Inc. on Make Money, Make Time’s Substack by Oliver | MMMT Wealth. In this article, we will summarize the bulls’ thesis on HROW. Harrow, Inc.'s share was trading at $47.88 as of September 24th. HROW’s trailing and forward P/E were 9.64 and 51.55 respectively according to Yahoo Finance.
Harrow Pharmaceuticals (HROW) is a U.S.-based ophthalmology-focused pharmaceutical company headquartered in Nashville, operating across three main pillars: FDA-approved drugs, compounded formulations, and equity stakes in emerging innovators. Its...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.